Therapeutics

Research studying the use of new and existing drugs for combating the virus

Published and Preprint Papers

Drugs

Title

Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection.

Activation of PXR causes drug interactions with Paxlovid in transgenic mice.

Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study.

atorvastatin, rosuvastatin

A Retrospective Cohort Study Assessing the Impact of Statin Therapy on Hospital Length of Stay and Inpatient Mortality in COVID-19 Patients.

Upamostat: a serine protease inhibitor for antiviral, gastrointestinal and anticancer indications.

What is the Optimal Treatment Regimen of Low-MolecularWeight Heparin in Coronavirus Disease 2019 Pneumonia?

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.

Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study.

Probiotics for the prevention and treatment of COVID-19: a rapid systematic review and meta-analysis.

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2.